KDR and central nervous system cancer: Previous research has revealed that genetic mutations and polymorphisms are closely related to disease susceptibility and can lead to different responses to environmental factors and drugs.[15–17] Thus far, many studies have reported an association between the VEGFR2 gene polymorphism rs2305948 and glioma risk, but the results of individual studies have been inconsistent.